A wealth of structural information is now available about DNA-protein recognition, largely from crystallographic and NMR studies of DNA-protein complexes. In comparison, relatively little is known about RNA-protein recognition. The most detailed information is provided by the cocrystal structures of three tRNA synthetase-tRNA complexes (1-5), an R17 coat protein-RNA complex (6), and a UlA ribonucleoprotein domain-RNA complex (7). In the synthetase complexes, sequence-specific contacts occur primarily in the minor groove of tRNAGln (1, 2), in the major groove of tRNAAsP (3, 4), and to the phosphate backbone of tRNASer (5). Important contacts also are made to anticodon loop nucleotides in the glutaminyl and aspartyl complexes. The overall structures of the synthetases are rather different, and aside from RNA conformational changes observed upon binding, few general features of recognition have emerged. In the R17 and UlA complexes, the most important sequence-specific contacts are made to bulge and loop nucleotides of RNA hairpins (6, 7).
mation of the peptide. Similar features have been observed in protein-DNA and drug-DNA complexes in the DNA minor groove, including hydrophobic interactions and binding deep within the groove, suggesting that the major groove of RNA and minor groove of DNA may share some common recognition features.
A wealth of structural information is now available about DNA-protein recognition, largely from crystallographic and NMR studies of DNA-protein complexes. In comparison, relatively little is known about RNA-protein recognition. The most detailed information is provided by the cocrystal structures of three tRNA synthetase-tRNA complexes (1) (2) (3) (4) (5) , an R17 coat protein-RNA complex (6) , and a UlA ribonucleoprotein domain-RNA complex (7) . In the synthetase complexes, sequence-specific contacts occur primarily in the minor groove of tRNAGln (1, 2) , in the major groove of tRNAAsP (3, 4) , and to the phosphate backbone of tRNASer (5) . Important contacts also are made to anticodon loop nucleotides in the glutaminyl and aspartyl complexes. The overall structures of the synthetases are rather different, and aside from RNA conformational changes observed upon binding, few general features of recognition have emerged. In the R17 and UlA complexes, the most important sequence-specific contacts are made to bulge and loop nucleotides of RNA hairpins (6, 7) .
Recently, several common RNA-binding motifs have been identified (for review, see refs. 8 and 9), suggesting that conserved structural features may be found in some classes of proteins. One of these motifs, the arginine-rich motif, consists of a short region of basic amino acids (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) residues long) particularly rich in arginine. This motif has been found in bacterial antiterminators, ribosomal proteins, coat proteins from RNA viruses, the human immunodeficiency virus (HIV) Tat and Rev proteins (10) , and the bovine immunodeficiency virus (BIV) Tat protein (11) . Studies with model peptides derived from the arginine-rich domains of HIV Rev, HIV Tat, and BIV Tat have emphasized the importance of RNA structure in protein recognition and have provided some details about sequence-specific interactions (11) (12) (13) (14) (15) (16) . In HIV Rev, a 17-amino acid peptide specifically recognizes the Rev response
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. element (RRE) RNA when the peptide is in an a-helical conformation and uses 6 amino acids (4 arginines, 1 threonine, and 1 asparagine) for binding (12) . NMR studies have shown that binding induces formation of an internal loop structure in the RRE containing GG and GA base pairs and two loopedout bases (17, 18) . In HIV Tat, a single arginine residue within a 9-amino acid peptide is largely responsible for recognition of a bulge region in transactivation response element (TAR) RNA (14) . The free amino acid arginine binds to TAR by using a similar set of RNA structural features (19) , suggesting that a defined peptide conformation may not be needed for rec- ognition. An NMR model of the arginine-TAR complex suggests that the guanidinium group of arginine hydrogen bonds to a guanine base in the major groove and to two phosphates on the backbone and that the complex is stabilized by a base triple interaction between a uracil in the bulge and an A-U base pair above the bulge (15) . In both cases, bulges help widen the major grooves of adjacent A-form RNA helices, thereby increasing accessibility to the proteins (13, 20) .
BIV Tat is closely related to HIV Tat; however, initial studies with a 17-amino acid peptide suggested that BIV Tat uses a very different set of interactions to recognize BIV TAR (11) . The peptide binds to an unusually accessible stem region adjacent to two single-nucleotide bulges in BIV TAR and requires an extensive set of determinants in the major groove ( Fig. 1) very different from those of HIV TAR. The sequence of the BIV peptide also is distinct, containing several glycine and proline residues in addition to arginine residues (Fig. 1) . In this study, we show that three glycine residues in the peptide are critical for BIV TAR recognition and, most surprisingly, that an isoleucine also is critical. We suggest that the isoleucine intercalates between bases in the major groove of BIV TAR and that glycine residues allow the peptide to bind deeply in the groove, analogous to interactions observed in the minor groove of DNA. .6 50-
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Proc. NatL Acad ScL USA 92 (1995) that the decreased activities observed in vivo reflected true effects on RNA-binding affinity, peptides were synthesized corresponding to the most impaired mutants and affinities were measured by a gel mobility shift assay. All mutants showed a significant reduction in BIV TAR binding affinity (Fig. 2B) . In some cases (the Thr-72 mutant in particular), the peptide-RNA complex migrated significantly faster than the wild-type complex, suggesting that the structure of the bound RNA might be different (see below). Peptides having deletions of the three N-terminal residues [BIV Tat-(68-81)] or the three N-terminal and two C-terminal residues [BIV Tat-(68-79)] bound BIV TAR with the same affinity as the wild-type peptide, further indicating that Ser-65, Gly-66, Pro-67, Arg-80, and Arg-81 are not involved in RNA binding. We cannot rule out the possibility that Arg-68 and Arg-78 contribute important electrostatic or hydrogen bonding interactions since their substitution with lysine, which may still form these interactions, had little effect on activity (Fig. 2A) .
Isoleucine Mutants. One surprising result of the mutagenesis was that a hydrophobic side chain (isoleucine) was required. To examine the role of this residue in more detail, we replaced Ile-79 with 15 other amino acids and measured RNA-binding activities of these mutants in vivo. While the isoleucine side chain provided the optimal interaction, other hydrophobic residues of similar size (leucine, tyrosine, or phenylalanine) could substitute reasonably well (20-30% of wild-type activity; (Fig. 4A) . Addition of 50% (vol/vol) trifluoroethanol (TFE), which often stabilizes a-helical peptide conformations (23) , induced a change in the spectrum consistent with a mixture of random coil and a small amount of }3-sheet and/or X3-turn. The difference spectrum shows a single minimum near 218 nm (Fig. 4B) and is similar to the TFE-induced spectra of a 13-hairpin fragment of streptococcal protein G (24) and other peptides with l3 tendencies (25) . A similar change in the BIV peptide spectrum was observed in the presence of low concentrations of SDS (data not shown), which also has been proposed to stabilize 13 conformations (25) . In contrast, addition of 50% TFE to an HIV Tat peptide (YGRKKRQRRRP) showed a small amount of a-helix formation with characteristic double minima at 208 and 222 nm (data not shown), consistent with the helical tendency observed by NMR (26) . It should be emphasized that CD spectra of 13 structures are not as well defined as spectra of a-helices and the effects of TFE are less well understood; however, preliminary NMR experiments are consistent with a hairpin conformation for the BIV peptide (J.
Puglisi, L.C., and A.D.F., unpublished data). The CD spectra of mutant peptides with decreased RNA-binding affinities (70RK, 72TA, 73RK, 77RK, 791A, 791Y, and 79IN; Figs. 2B and 3B) were identical to those of the wild-type peptide in aqueous buffer or in 50% TFE (data not shown), suggesting that these mutations probably alter direct interactions with the RNA and not the conformational tendency of the peptide. The spectrum of the 74GA mutant in 50% TFE was slightly different from that of the wild-type peptide (data not shown), suggesting that the glycine may influence the conformational preference of the peptide.
CD experiments also were used to monitor possible conformational changes in BIV TAR upon peptide binding, as for HIV Tat-TAR (27) and Rev-RRE (28) complexes. We recorded spectra of the free RNA and a peptide-RNA complex (Fig. 4C ) and calculated the difference spectrum (Fig. 4D) .
The minimum in the difference spectrum observed near 280 nm corresponds to ellipticity from the RNA and is consistent with a change in base stacking. The minimum observed near 218 nm is consistent with a 1 conformation of the peptide in the complex but also is likely to reflect changes in RNA conformation as the free RNA contributes ellipticity at this wavelength. The minimum observed near 200 nm may also reflect contributions from both the RNA and peptide. CD difference spectra with mutant peptide-RNA complexes were slightly different from the wild-type complex (data not shown), perhaps suggesting subtle differences in RNA structure and possibly relating to the differences in gel mobility described (25 ,uM) in aqueous buffer and in 50% TEE. (B) Difference CD spectrum representing the change in peptide structure induced by 50% TFE. The difference spectrum was calculated by subtracting the spectrum of the peptide in aqueous buffer from the spectrum in the presence of 50% TEE. (C) CD spectra of free BIV TAR RNA (16 ,uM) and a peptide-RNA complex at 1:1 stoichiometry. (D) Difference CD spectrum of bound and free BIV TAR RNA. The spectrum of unbound BIV TAR was subtracted from the spectrum of the peptide-RNA complex.
above. The nature of these differences will require more detailed structural studies.
Thermostability of the Peptide-RNA Complex. Specific peptide binding was found to significantly enhance the thermostability of BIV TAR. In the absence of peptide, the RNA showed a single cooperative UV melting transition with Tm = 74°C, AH = -73 kcal/mol, and AS = 210 cal per K per mol ( Fig. SA; 1 (Fig. SB) . The 74GA mutant binds BIV TAR with little or no specificity (relative to mutant TAR RNAs) and stabilizes the RNA to the same extent (5°C) as the ionic stabilization of Mg2e. The unstructured nature of the free peptide and the increased thermostability of the RNA in the complex suggest that the peptide probably undergoes a disorder --order transition that is tightly coupled to specific RNA binding. In the Rev-RRE interaction, the helical conformation of the peptide is stabilized upon specific RNA binding (28), although some preformed structure is required (12) . In many DNA-protein interactions, disordered regions of proteins also appear to become ordered upon specific binding (29) .
DISCUSSION
The interaction of the BIV Tat peptide with RNA is quite different from the interaction of HIV Tat or Rev arginine-rich peptides with RNA. The specificity of the HIV Tat-TAR interaction is determined largely by the contact of a single arginine residue, placed in the context of basic amino acids, with a bulge region in TAR (14, 15, 30) . In contrast, the HIV Rev-RRE interaction requires 6 amino acids (4 arginines, 1 threonine, and 1 asparagine), placed in the context of an a-helix, to bind specifically to an internal loop region in the RRE (12) . As with Rev, the BIV Tat-TAR interaction requires several arginine residues and one threonine but in addition requires one isoleucine and three glycine residues. The CD data provide preliminary evidence that the BIV peptide has a tendency to adopt a X3 conformation (although we do not know the conformation of the bound peptide), suggesting that arginine-rich RNA-binding peptides may be (38) , and intercalation of a leucine in a PurR-DNA complex (39) .
Mutation of the isoleucine in SRY (an HMG-box protein) reduces DNA-binding affinity and is associated with phenotypic sex reversal (38) , and the leucine in PurR is highly conserved among related DNA-binding repressors (39) . Be (40) , and an isoleucine mutation in the putative RNA-binding domain of the FMR1 protein has been associated with fragile X chromosome syndrome and causes decreased nonspecific RNA-binding affinity (41) , suggesting that hydrophobic contacts will make important contributions in other RNA-protein interactions.
